Data from: G protein regulatory network shapes magnitude and kinetics of behavioral responses in an engineered opioid receptor model
Data files
Apr 22, 2026 version files 5.58 MB
-
Figure_1_Stats_Analysis.prism
1.06 MB
-
Figure_2_Stats_Analysis.prism
625.34 KB
-
Figure_3_Stats_Analysis.prism
523.46 KB
-
Figure_4_Stats_Analysis.prism
532.38 KB
-
Figure_5_Stats_Analysis.prism
515.97 KB
-
Figure_6_Stats_Analysis.prism
245.39 KB
-
README.md
17.07 KB
-
Supplemental_Figure_2_Stats_Analysis.prism
533.66 KB
-
Supplemental_Figure_3_Stats_Analysis.prism
424.46 KB
-
Supplemental_Figure_4_Stats_Analysis.prism
445.40 KB
-
Supplemental_Figure_5_Stats_Analysis.prism
474.84 KB
-
Supplemental_Figure_6_Stats_Analysis.prism
180.83 KB
Abstract
G protein-coupled receptors (GPCRs) control essential neuronal functions. One GPCR with prominent effects on the nervous system and animal behavior is the mu-opioid receptor (MOR). GPCRs mediate their effects by engaging a gamut of G proteins, which are inhibited by Regulators of G protein Signaling (RGS). At present, how different RGS proteins regulate the magnitude and temporal kinetics of G protein signaling to affect behavior remains unclear. Here, we use an engineered cross-species Caenorhabditis elegans model of MOR signaling (tgMOR) to test how multiple RGS proteins shape MOR signaling and behavioral responses to opioids. Our results indicate opioid-induced effects on locomotor behavior in tgMOR are primarily mediated by Gαo and are modified by opposing Gαq action. We further delineate that EGL-10 (RGS7) is a primary RGS that modulates the magnitude of MOR-meditated responses. In a differential effect, EAT-16 (RGS9) and its regulator RSBP-1 (R7BP) principally influence the timing of behavioral response onset. Thus, a multi-layered RGS network is required to shape the magnitude and kinetics of MOR signaling and ensuing behavioral responses to opioids. The G protein regulatory network revealed here might also have broader implications for other Gαo/i-coupled receptors.
Dataset DOI: 10.5061/dryad.x69p8czzd
Description of the data and file structure
Prism files that contain statistical analyses.
Files and variables
File: Figure_1_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Figure 1. TgMOR Caenorhabditis elegans display dose-sensitive behavioral responses to fentanyl that are inhibited by naloxone and absent in non-transgenic animals. Computationally automated tracking of locomotion in liquid using MWT showing reduced locomotor speed of tgMOR C. elegans treated with 40 μM fentanyl. C) quantitation shows tgMOR C. elegans display stronger reductions in locomotion with increasing fentanyl dose. Shown are MWT plots of average locomotor speed and expanded quantitation at set time point 10 min after fentanyl or vehicle treatment. D, quantitation of percent magnitude of fentanyl effects quantitated using area under the curve shows stronger effects with increasing dose. E, time to maximum effect for fentanyl is shorter with increasing dose. F–H, pretreating tgMOR with naloxone (20 μM) for 30 min reduce effects of fentanyl (20 μM). I, naloxone (20 μM) reverses effects of fentanyl (40 μM) on tgMOR animals. J, high-dose fentanyl (80 μM) impairs locomotion of tgMOR C. elegans but not wt non-transgenic animals. K, fentanyl effects on tgMOR animals are not altered in tgMOR; npr-17 mutants. C, F, I, J and K, plots represent mean speed of tracked animals (4 animals/well, five wells per genotype per experiment and 3–4 independent experiments for all genotypes and treatments). Dots represent single wells tracked (4 animals/well), lines represent average for all wells, and error bars are SEM. Plots are normalized to 10-min baseline locomotor speed prior to treatment. Significance for plots was tested using two-way ANOVA with post hoc Bonferroni correction for multiple comparisons, and set time point comparisons were tested using one-way ANOVA with Bonferroni correction. D and G, bars represent average for all wells and error bars are SEM. E and H, dots represent single wells tracked, lines represent average for all wells, and error bars are SEM. D and E, significance tested using one-way ANOVA with Bonferroni correction. G and H, significance tested using Student's t test. ∗∗∗p < 0.001, ∗p < 0.05, ns = not significant. MWT, multi-worm tracker
File: Figure_2_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Figure 2. GOA-1 Gαo mediates effects of fentanyl on tgMOR C. elegans. E, quantitation shows tgMOR; goa-1 mutant's display impaired sensitivity to 40 μM and 80 μM fentanyl compared to tgMOR animals. Shown are MWT plots of average locomotor speed normalized to vehicle control and expanded quantitation at set time point 10 min after fentanyl treatment for indicated genotypes. F, quantitation shows two tgMOR; goa-1 mutant alleles (bgg216 and n363) display impaired sensitivity to 40 μM fentanyl. G, magnitude of fentanyl effects shows two tgMOR; goa-1 mutants (bgg216 and n363) display impaired responses to fentanyl compared to tgMOR controls. H, time to maximum effect for fentanyl shows no significant difference between tgMOR; goa-1 mutants and tgMOR controls. E and F, plots represent mean speed of tracked animals (4 animals/well, four wells per genotype per experiment and 3 to 4 independent experiments for all genotypes and treatments). Dots represent single wells tracked (4 animals/well), lines represent average for all wells, and error bars are SEM. Significance for plots was tested using two-way ANOVA with post hoc Bonferroni correction, and set time point comparisons were tested using one-way ANOVA with Bonferroni correction. G, bars represent average for all wells and error bars are SEM. H, dots represent single wells tracked, lines represent average for all wells, and error bars are SEM. G and H, significance tested using one-way ANOVA with Bonferroni correction. ∗∗∗p < 0.001, ∗∗p < 0.01, ns = not significant. MWT, multi-worm tracker
File: Figure_3_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Figure 3. EGL-10 RGS negatively regulates magnitude of locomotor responses to fentanyl. E, quantitation shows tgMOR; egl-10 mutants display increased sensitivity to 20 μM and 40 μM fentanyl. Shown are MWT plots of average locomotor speed normalized to vehicle control and expanded quantitation at set time point 10 min after fentanyl treatment. F, quantitation shows two tgMOR; egl-10 mutant alleles (bgg221 and md176) display stronger sensitivity to 40 μM fentanyl. G, magnitude of fentanyl effects is stronger in two tgMOR; egl-10 mutants (bgg221 and md176) compared to tgMOR control animals. H, time to maximum effect for fentanyl is inconsistently affected in tgMOR; egl-10 mutants. E and F, plots represent mean speed of tracked animals (4 animals/well, five wells per genotype per experiment and 3–4 independent experiments for all genotypes and treatments). Dots represent single wells tracked (4 animals/well), lines represent average for all wells, and error bars are SEM. Significance for plots was tested using two-way ANOVA with post hoc Bonferroni correction, and set time point comparisons were tested using one-way ANOVA with Bonferroni correction. G, bars represent average for all wells and error bars are SEM. H, dots represent single wells tracked, lines represent average for all wells, and error bars are SEM. G and H, significance tested using one-way ANOVA with Bonferroni correction. ∗∗∗p < 0.001, ∗p < 0.05, ns, not significant; MWT, multi-worm tracker
File: Figure_4_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Figure 4. EAT-16 RGS restrains temporal kinetics of locomotor responses to fentanyl. C, quantitation shows tgMOR; eat-16 mutants display increased sensitivity in time of response to 40 μM and 80 μM fentanyl as well as reduced magnitude of response. Shown are MWT plots of average locomotor speed normalized to vehicle control and expanded quantitation at set time point 10 min after fentanyl treatment. D, quantitation shows two tgMOR; eat-16 mutant alleles (bgg219 and tm761) display increased sensitivity in time of response to 80 μM fentanyl. E, magnitude of fentanyl effects are weakened in both tgMOR; eat-16 mutants (bgg219 and tm761) compared to tgMOR control animals. F, time to maximum effect for fentanyl is stronger and occurs faster in tgMOR; eat-16 mutants compared to tgMOR controls. C and D, MWT plots represent mean speed of tracked animals (4 animals/well, five wells per genotype per experiment and 3 to 5 independent experiments for all genotypes and treatments). Dots represent single wells tracked (4 animals/well), lines represent average for all wells, and error bars are SEM. Significance for plots was tested using two-way ANOVA with post hoc Bonferroni correction, and set time point comparisons were tested using one-way ANOVA with Bonferroni correction. For E, bars represent average for all wells and error bars are SEM. For F, dots represent single wells tracked, lines represent average for all wells, and error bars are SEM. E and F, significance tested using one-way ANOVA with Bonferroni correction. ∗∗∗p < 0.001. MWT, multi-worm tracker.
File: Figure_5_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Figure 5. EAT-16 RGS restrains temporal kinetics of locomotor responses to fentanyl. C, quantitation shows tgMOR; eat-16 mutants display increased sensitivity in time of response to 40 μM and 80 μM fentanyl as well as reduced magnitude of response. Shown are MWT plots of average locomotor speed normalized to vehicle control and expanded quantitation at set time point 10 min after fentanyl treatment. D, quantitation shows two tgMOR; eat-16 mutant alleles (bgg219 and tm761) display increased sensitivity in time of response to 80 μM fentanyl. E, magnitude of fentanyl effects are weakened in both tgMOR; eat-16 mutants (bgg219 and tm761) compared to tgMOR control animals. F, time to maximum effect for fentanyl is stronger and occurs faster in tgMOR; eat-16 mutants compared to tgMOR controls. C and D, MWT plots represent mean speed of tracked animals (4 animals/well, five wells per genotype per experiment and 3 to 5 independent experiments for all genotypes and treatments). Dots represent single wells tracked (4 animals/well), lines represent average for all wells, and error bars are SEM. Significance for plots was tested using two-way ANOVA with post hoc Bonferroni correction, and set time point comparisons were tested using one-way ANOVA with Bonferroni correction. For E, bars represent average for all wells and error bars are SEM. For F, dots represent single wells tracked, lines represent average for all wells, and error bars are SEM. E and F, significance tested using one-way ANOVA with Bonferroni correction. ∗∗∗p < 0.001. MWT, multi-worm tracker.
File: Figure_6_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Figure 6. Constitutively activating EGL-30 Gαq reduces locomotor responses to fentanyl. C, magnitude of fentanyl effects is weaker in tgMOR; egl-30 GOF mutants compared to tgMOR control animals. D, time to maximum effect for fentanyl is reduced and occurs faster in tgMOR; egl-30 GOF mutants compared to tgMOR controls. E, proposed endogenous C. elegans G protein regulatory network that imbues tgMOR C. elegans with sensitivity to opioids, and that shapes the magnitude and temporal kinetics of opioid-induced effects on locomotor behavior. B, plots represent mean speed of tracked animals (4 animals/well, five wells per genotype per experiment and four independent experiments for all genotypes and treatments). Dots represent single wells tracked (4 animals/well), lines represent average for all wells, and error bars are SEM. Significance for plots was tested using two-way ANOVA, and set time point comparisons were tested using Student's t test. D, bars represent average for all wells and error bars are SEM. D, dots represent single wells tracked, lines represent average for all wells, and error bars are SEM. C and D, significance tested using Student's t test. ∗∗∗p < 0.001, ∗∗p < 0.01. MWT, multi-worm tracker
File: Supplemental_Figure_2_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Supplemental Figure 2. Expanded analysis of MWT data showing GOA-1 Gao mediates effects of fentanyl on tgMOR C. elegans**. **A-B) Quantitation of A) raw locomotor speed and B) speed normalized to pre-treatment baseline locomotion shows tgMOR; goa-1 (bgg216) mutants have reduced sensitivity to 80µM fentanyl. C-D) Quantitation of C) raw locomotor speed and D) speed normalized to pre-treatment baseline indicates tgMOR; goa-1 (bgg216) mutants have reduced responses to 40µM fentanyl. E-F) Quantitation of E) raw locomotor speed and F) speed normalized to pre-treatment baseline shows tgMOR; goa-1 shows tgMOR; goa-1 (n363) mutants have reduced responses to 40µM fentanyl. For A-F, solid lines in plots represent mean speed of tracked animals (4 animals/well, 5 wells per genotype per experiment and 3-4 independent experiments for all genotypes and treatments). For B, D, and F, significance for genotype annotations in plots tested using two-way ANOVA with post-hoc Bonferroni correction for multiple comparisons. ***P < 0.001
File: Supplemental_Figure_3_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Supplemental Figure 3. Expanded analysis of MWT data for tgMOR; egl-10 mutants. A-B) Quantitation of A) raw locomotor speed and B) speed normalized to pre-treatment baseline locomotion shows** tgMOR; egl-10 (bgg221) mutants have increased sensitivity to 40µM fentanyl. C-D) Quantitation of C) raw locomotor speed and D) speed normalized to pre-treatment baseline indicates tgMOR; egl-10 (bgg221)** mutants have increased responses to 20µM fentanyl. E-F) Quantitation of E) raw locomotor speed and F) speed normalized to pre-treatment baseline shows tgMOR; egl-10 (md176)** mutants have increased responses to 20µM fentanyl. For A-F, solid lines in plots represent mean speed of tracked animals (4 animals/well, 5 wells per genotype per experiment and 3-4 independent experiments for all genotypes and treatments). For B, D, and F, significance for genotype annotations in plots tested using two-way ANOVA with post-hoc Bonferroni correction for multiple comparisons. ***P < 0.001
File: Supplemental_Figure_5_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Supplemental Figure 5. Expanded analysis of MWT data for tgMOR; rsbp-1 mutants. A-B) Quantitation of A) raw locomotor speed and B) speed normalized to pre-treatment baseline locomotion shows tgMOR; rsbp-1 (bgg174) mutants have increased sensitivity in time of response to 80µM fentanyl as well as reduced amplitude of response. C-D) Quantitation of C) raw locomotor speed and D) speed normalized to pre-treatment baseline indicates tgMOR; rsbp-1 (bgg174) mutants have increased sensitivity in time of response to 40µM fentanyl as well as reduced amplitude of response. E-F) Quantitation of E) raw locomotor speed and F) speed normalized to pre-treatment baseline shows tgMOR; rsbp-1 (vs163) mutants have increased sensitivity in time of response to 80µM fentanyl as well as reduced amplitude of response. For A-F, solid lines in plots represent mean speed of tracked animals (4 animals/well, 5 wells per genotype per experiment and 4 independent experiments for all genotypes and treatments). For B, D, and F, significance for genotype annotations in plots tested using two-way ANOVA with post-hoc Bonferroni correction for multiple comparisons. ***P < 0.001
File: Supplemental_Figure_4_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Supplemental Figure 4. Expanded analysis of MWT data for tgMOR; eat-16 mutants. A-B) Quantitation of A) raw locomotor speed and B) speed normalized to pre-treatment baseline locomotion shows tgMOR; eat-16 (bgg219) mutants have increased sensitivity in time of response to 80µM fentanyl as well as reduced amplitude of response. C-D) Quantitation of C) raw locomotor speed and D) speed normalized to pre-treatment baseline indicates tgMOR; eat-16 (bgg219) mutants have increased sensitivity in time of response to 40µM fentanyl as well as reduced amplitude of response. E-F) Quantitation of E) raw locomotor speed and F) speed normalized to pre-treatment baseline shows tgMOR; eat-16 (tm761) mutants have increased sensitivity in time of response to 80µM fentanyl as well as reduced amplitude of response. For A-F, solid lines in plots represent mean speed of tracked animals (4 animals/well, 5 wells per genotype per experiment and 3-5 independent experiments for all genotypes and treatments). For B, D, and F, significance for genotype annotations in plots tested using two-way ANOVA with post-hoc Bonferroni correction for multiple comparisons. ***P < 0.001
File: Supplemental_Figure_6_Stats_Analysis.prism
Description: Prism files that contain statistical analyses for Supplemental Figure 6. Expanded analysis of MWT data for tgMOR; egl-30 mutants. A-B) Quantitation of A) raw locomotor speed and B) speed normalized to pre-treatment baseline locomotion shows tgMOR; egl-30 (bgg169) mutants have decreased sensitivity to 80µM fentanyl. Arrow indicates fentanyl or vehicle application. For A and B, solid lines in plots represent mean speed of tracked animals (4 animals/well, 5 wells per genotype per experiment and 4 independent experiments for all genotypes and treatments). For B, Significance for genotype annotations in plots was tested using two-way ANOVA with post-hoc Bonferroni correction for multiple comparisons. ***P < 0.001
Code/software
GraphPad Prism version 10 or newer.
